Home
Live Updates
Ocugen to Present on Modifier Gene Therapy Platform at : comparemela.com
Ocugen to Present on Modifier Gene Therapy Platform at
MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,...
Related Keywords
,
Nieraj Jain ,
Tarun Upadhyay ,
Joses Pulido ,
Murthy Chavali ,
Shankar Musunuri ,
Borooah Shyamanga ,
Benjamin Bakall ,
Arunk Upadhyay ,
Nalin Mehta ,
Sahar Matloob ,
Paul Yang ,
University Of Miami ,
Ocugen Inc ,
Head Of Research Development ,
Seattle Convention Center ,
Nuclear Hormone Receptor ,
Exchange Commission ,
Head Of Communications ,
Association For Research ,
Linkedin ,
Clinical Development ,
Hormone Receptor Based Gene Modifier Therapy ,
Retinitis Pigmentosa Associated ,
Byron Lam ,
Endowed Chair ,
March Building ,
Gene Agnostic Modifier Therapy ,
Retinitis Pigmentosa ,
Study Results ,
Melight Study Design ,
Chief Scientific Officer ,
Show Floor ,
Educational Lounge ,
Multifactorial Therapeutic Intervention ,
Dry Age Related Macular Degeneration ,
Huma Qamar ,
Chief Medical Officer ,
Novel Modifier Approach ,
Orphan Receptor ,
Private Securities Litigation Reform Act ,
Nasdaq Ocgn ,
Ocugen ,
Biotechnology ,
Ophthalmology ,
Gene Therapy ,
comparemela.com © 2020. All Rights Reserved.